Bastida et al. [8] designed a gene panel targeting F8, F9 and VWF on an Illumina MiSeq platform whereas Bastida et al. [9] used a 23-gene panel to target both common and rare bleeding disorders using the same platform. Here, VWF is linked to hemorrhagic disease.